HEALTHCARE ROYALTY PARTNERS

We are a $3.0+ billion global healthcare investment firm. We invest primarily in commercial stage healthcare product assets that have significant clinical value, strong barriers to entry and that are marketed by some of the worldโs largest pharmaceutical companies. Over the past decade, our senior investment team has completed more than 60 royalty investments valued in excess of $2.5 billion. For more information, visit www.healthcareroyalty.com.
HEALTHCARE ROYALTY PARTNERS
Social Links:
Industry:
Asset Management Biotechnology Financial Services Medical Device Pharmaceutical
Founded:
2007-01-01
Status:
Active
Contact:
203.487.8300
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Domain Not Resolving Wordpress Plugins
Current Advisors List
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-08-08 | Clearside Biomedical | HealthCare Royalty Partners investment in Post-IPO Debt - Clearside Biomedical | 65 M USD |
2022-06-30 | Ardelyx | HealthCare Royalty Partners investment in Post-IPO Debt - Ardelyx | 20 M USD |
2022-06-16 | Rhythm Pharmaceuticals | HealthCare Royalty Partners investment in Post-IPO Debt - Rhythm Pharmaceuticals | 37.5 M USD |
2021-09-30 | Spero Therapeutics | HealthCare Royalty Partners investment in Post-IPO Debt - Spero Therapeutics | 125 M USD |
2019-03-04 | Portola Pharmaceuticals | HealthCare Royalty Partners investment in Post-IPO Debt - Portola Pharmaceuticals | 125 M USD |
2019-01-08 | Coherus Biosciences | HealthCare Royalty Partners investment in Post-IPO Debt - Coherus Biosciences | 75 M USD |
2016-04-14 | TearScience | HealthCare Royalty Partners investment in Series D - TearScience | 19.23 M USD |
2015-02-13 | Invuity | HealthCare Royalty Partners investment in Private Equity Round - Invuity | 22.9 M USD |
2014-11-13 | Helomics | HealthCare Royalty Partners investment in Series E - Helomics | 60 M USD |
2014-09-18 | Cardiorentis | HealthCare Royalty Partners investment in Series A - Cardiorentis | 45 M EUR |